Form D · Other Technology
Wildflower Health, Inc.
San Francisco, CA · CIK 0001593748
Offering snapshot reported Dec 11, 2024 · SEC filing
- Reported sold
- $17.9M Offering amount: $19.9M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 27, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 11, 2024 | Initial | $17,939,793 | No comparison | 12 | SEC filing |
| Dec 9, 2013 | Initial | $1,705,790 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-531703
"Total amount sold" includes $12,939,793.71 of Series 1-1 Preferred Stock issued upon conversion of Convertible Notes.
Source: Form D, filed Dec 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Katherine Bellevin | Director, Executive |
| John Crumpler | Director |
| Dan Galles | Director |
| Steven Lefar | Director |
| Ezra Mehlman | Director |
| Dawn Owens | Director |
| Kim Russell | Executive |
| Ralph Sabin | Director |
| Leah Sparks | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2443 Fillmore Street #380 6499
San Francisco, CA, 94115
San Francisco, CA, 94115